← Scroll for more →
Financial Statements — RCT
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | 0.48 | 0.87 | 0.80 |
| Accounts Receivable | 2.77 | 2.49 | 5.53 |
| Total Current Assets | 5.34 | 5.76 | 10.80 |
| Property, Plant & Equipment | 0.44 | 0.57 | 0.59 |
| Intangible Assets | 6.73 | 7.07 | 6.17 |
| Total Non-current Assets | 7.31 | 7.65 | 6.76 |
| Total Assets | 12.65 | 13.40 | 17.56 |
| Accounts Payable | 2.36 | 4.23 | 3.37 |
| Short-term Debt | 3.77 | 0.32 | 0.56 |
| Total Current Liabilities | 19.62 | 21.41 | 63.77 |
| Total Non-current Liabilities* | 0.00 | 22.56 | 22.56 |
| Total Liabilities | 19.62 | 21.41 | 86.33 |
| Retained Earnings | (194.66) | (174.97) | (148.42) |
| Total Stockholder Equity | (6.96) | (8.00) | (68.77) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 17.97 |
| Selling, General & Admin | 1.35 |
| Total Operating Expenses | 37.97 |
| Operating Income | (20.00) |
| Pretax Income | (27.03) |
| Tax Provision | (0.49) |
| Net Income | (26.54) |
| Basic EPS | (0.74) |
| Diluted EPS | (0.74) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | (15.92) |
| Capital Expenditures | 0.13 |
| Free Cash Flow* | (16.04) |
| Investing Cash Flow | (2.23) |
| Financing Cash Flow | 20.73 |
← Scroll for more columns →
* Derived from reported values